HR vs WELL: Which Is the Better Buy in 2026?

Last updated October 2026

Short answer

WELL is the larger of the two ($169.23B market cap): the incumbent the market prices for continued execution (73.85x forward earnings, beta 0.75). HR is the smaller challenger ($6.13B), actually pricier on forward earnings (388.44x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.

HR vs WELL: the tie-breaker metrics

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricHRWELLWhat it tells you
Market cap$6.13B$169.23BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E388.4473.85Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Beta0.840.75Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range20% of range75% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book1.423.64How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Reading it: WELL is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

Before you buy: how HR and WELL affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. HR and WELL share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined HR and WELL exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Healthcare Realty Trust (HR) do?

Healthcare Realty Trust is a real estate investment trust focused on outpatient medical facilities, primarily medical office buildings leased to health systems, physician groups, and related healthcare tenants, with properties concentrated on or near acute-care hospital campuses. The company became the largest dedicated owner of medical office real estate after its 2022 combination with Healthcare Trust of America, and it earns rent from a diversified base of healthcare providers whose demand tends to be less cyclical than other property types.

Full HR guide

What does Welltower (WELL) do?

Welltower Inc. is the largest healthcare REIT in the world, owning a portfolio of senior housing, assisted living, post-acute and long-term care, and outpatient medical real estate across the United States, the United Kingdom, and Canada. It makes money in two main ways: through its Senior Housing Operating Portfolio (SHOP), where it shares directly in the net operating income that property operators generate from residents, and through rents on triple-net leased seniors housing and care facilities plus outpatient medical buildings. Because SHOP income flows through to Welltower rather than being fixed rent, rising occupancy and room rates translate quickly into higher earnings, which is why the operating portfolio has become the company's main growth engine.

Full WELL guide

HR vs WELL: how do they differ?

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

  • HR drivers: Occupancy and leasing momentum; Same-store cash NOI growth.
  • WELL drivers: Aging-demographics senior-housing tailwind; Operating-portfolio NOI growth.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: As a REIT, HR is sensitive to interest rates, since higher rates raise borrowing costs and can compress the price investors pay for its cash flows. For WELL, welltower's share price is sensitive to interest rates, since higher rates raise borrowing costs and make REIT dividend yields less competitive against bonds.

HR or WELL: which should you pick?

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick HR if you believe its drivers more; WELL if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the HR and WELL guides.

HR vs WELL: the full fundamentals

HR. REITs are usually valued on FFO per share and dividend yield rather than standard price-to-earnings, because large non-cash depreciation charges understate GAAP earnings, which is why HR shows a net loss. At about $17.38 on October 16, 2026, HR traded near 5.3x sales with a quarterly dividend of $0.24 a share, a yield of about 5.5%, and analysts' mean target was about $21. The Q3 report on October 29 will update normalized FFO and the 2.0 plan's progress.

WELL. Healthcare REITs are valued on funds from operations (FFO) rather than EPS, because standard net income is weighed down by large non-cash depreciation charges on real estate; that is why Welltower's GAAP P/E near 106x looks extreme. The key operating metric is senior-housing same-store NOI growth, now expected around 19% for 2026. At about $170 billion and a 1.45% yield, Welltower still carries a notably higher multiple than most healthcare REIT peers, and that premium is part of the investment case and part of the risk.

Headline figures (approximate, October 2026): HR shows market cap ~$6.1B, revenue (ttm) ~$1.15B, revenue growth (q2 2026, year over year) ~-4% (asset sales), net income (ttm, gaap) ~-$90M (depreciation-heavy); WELL shows revenue (ttm) ~$12.8 billion; Q2 2026 ~$3.54 billion, up ~39% YoY, net income (ttm) ~$1.55 billion GAAP (EPS ~$2.23), normalized ffo per share (2025) $5.29 (+~22.5%), 2026 senior-housing same-store noi growth ~19% expected after a raised outlook (original range 15% to 21%).

The bottom line: HR vs WELL

HR and WELL are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined HR and WELL exposure against your real portfolio. It is not an investment adviser.

Wondering how HR or WELL fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Investing in Healthcare Realty Trust with AI

Connect the broker you already use and ask Walnut's AI how HR fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

FAQ

What is the difference between HR and WELL?

+

Healthcare Realty Trust is a real estate investment trust focused on outpatient medical facilities, primarily medical office buildings leased to health systems, physician groups, and related healthcare tenants, with properties concentrated on or near acute-care hospital campuses. Welltower Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is HR or WELL the better stock?

+

Neither is universally better. WELL is the larger incumbent; HR is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, HR or WELL?

+

On forward P/E (as of October 2026), HR trades at 388.44x and WELL at 73.85x, so WELL is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both HR and WELL?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of HR vs WELL?

+

HR: As a REIT, HR is sensitive to interest rates, since higher rates raise borrowing costs and can compress the price investors pay for its cash flows. Its FFO payout leaves limited cushion, and the dividend has been trimmed in the past, so distribution coverage is worth watching. Integration of the large Healthcare Trust of America portfolio, tenant credit and move-outs, and elevated leverage relative to some peers add execution risk. Asset sales used to cut debt also dilute near-term earnings power, which shows up in revenue down about 4% year over year in Q2 2026 and a GAAP net loss over the trailing twelve months. Any broader weakness in commercial real estate values could weigh on the shares. The share price has been weak, down about 19% over three months and about 5% over one year to October 16, 2026, and analysts' consensus rating is Hold. WELL: Welltower's share price is sensitive to interest rates, since higher rates raise borrowing costs and make REIT dividend yields less competitive against bonds. The senior-housing operating model also carries labor cost and staffing pressures and depends on occupancy holding up, so a weaker demand environment or wage inflation could compress margins. The stock trades at a premium valuation relative to many healthcare REIT peers, which leaves limited room for disappointment and makes it vulnerable to multiple compression. The company is also deploying capital aggressively, so acquisition execution, integration, and the cost of financing that growth are real risks if returns on new investments fall short. The valuation premium is stark on reported earnings: at $235.74 the stock trades near 106x trailing GAAP EPS and about 13x sales, and total debt stands near $19.7 billion. Several brokers trimmed targets in October 2026 (Barclays to $246 from $259, Jefferies to $260 from $275), and rising bond yields were cited in the trade press as slowing REIT deal activity.

Related comparisons

Browse all stock comparisons.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell HR or WELL; figures are approximate and dated (as of October 2026). Verify current data before investing.